default author photo

Chunyang Li

SciClone Pharmaceuticals, Shanghai

Shanghai

China

  • SciClone Pharmaceuticals, Shanghai

SCHOLARLY PAPERS

1

DOWNLOADS

44

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Reassessing the Predictive and Prognostic Significance of ESR1 Mutations in HR+/HER2– Advanced Breast Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Number of pages: 35 Posted: 29 Jan 2026
Chengcheng Gong, Chunyang Li, Xiaoyan Zeng, Zhonghua Tao and Xichun Hu
Fudan University - Department of Oncology, SciClone Pharmaceuticals, Shanghai, SciClone Pharmaceuticals, Shanghai, Fudan University - Department of Oncology and Fudan University - Department of Oncology
Downloads 44 (1,196,171)

Abstract:

Loading...

ESR1 mutation, Hormone receptor-positive breast cancer, HER2-negative breast cancer, Selective estrogen receptor degrader (SERD), Meta-analysis